- Home
- XFOR vs ZJYL Comparison
XFOR vs ZJYL Comparison
Compare XFOR & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- ZJYL
- Stock Information
- Founded
- XFOR 2014
- ZJYL 2006
- Country
- XFOR United States
- ZJYL China
- Employees
- XFOR N/A
- ZJYL 269
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- ZJYL Industrial Specialties
- Sector
- XFOR Health Care
- ZJYL Consumer Discretionary
- Exchange
- XFOR Nasdaq
- ZJYL Nasdaq
- Market Cap
- XFOR 84.3M
- ZJYL 111.3M
- IPO Year
- XFOR N/A
- ZJYL 2023
- Fundamental
- Price
- XFOR $3.64
- ZJYL $0.61
- Analyst Decision
- XFOR Strong Buy
- ZJYL
- Analyst Count
- XFOR 3
- ZJYL 0
- Target Price
- XFOR $34.17
- ZJYL N/A
- AVG Volume (30 Days)
- XFOR 10.6M
- ZJYL 311.2K
- Earning Date
- XFOR 08-08-2025
- ZJYL 08-20-2025
- Dividend Yield
- XFOR N/A
- ZJYL N/A
- EPS Growth
- XFOR N/A
- ZJYL N/A
- EPS
- XFOR N/A
- ZJYL 0.01
- Revenue
- XFOR $32,774,000.00
- ZJYL $22,826,624.00
- Revenue This Year
- XFOR $1,313.84
- ZJYL N/A
- Revenue Next Year
- XFOR N/A
- ZJYL N/A
- P/E Ratio
- XFOR N/A
- ZJYL $57.23
- Revenue Growth
- XFOR 5721.31
- ZJYL 13.42
- 52 Week Low
- XFOR $1.35
- ZJYL $0.50
- 52 Week High
- XFOR $26.83
- ZJYL $4.08
- Technical
- Relative Strength Index (RSI)
- XFOR 51.62
- ZJYL 45.79
- Support Level
- XFOR $3.57
- ZJYL $0.61
- Resistance Level
- XFOR $4.83
- ZJYL $0.86
- Average True Range (ATR)
- XFOR 0.55
- ZJYL 0.07
- MACD
- XFOR -0.05
- ZJYL -0.00
- Stochastic Oscillator
- XFOR 26.94
- ZJYL 33.42
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.